Journal of the International AIDS SocietyVolume 19, Issue 1 21252 ErratumOpen Access Erratum This article corrects the following: HIV Vaccine Awareness Day: sustaining the momentum Kathleen M MacQueen, Mitchell Warren, Volume 19Issue 1Journal of the International AIDS Society First Published online: May 18, 2016 First published: 10 June 2016 https://doi.org/10.7448/IAS.19.1.21252AboutSectionsPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Regarding the paper ‘HIV Vaccine Awareness Day: sustaining the momentum’ by Kathleen M MacQueen, Mitchell Warren. Published in Journal of the International AIDS Society, Citation: MacQueen KM and Warren M. Journal of the International AIDS Society 2016, 19:21202. http://www.jiasociety.org/index.php/jias/article/view/21202 ∣ http://dx.doi.org/10.7448/IAS.19.1.21202 Reference 6 is missing in the reference list, and should be cited in the text according to the following: “This is no different than the requirements for advancing research on a cure for HIV [6], on new methods …”. The correct reference list is displayed below. References 1Snow B. Vaccine v. Cure: an HIV-positive perspective. In: B Snow, editor. HIV vaccine handbook: community perspectives on participating in research, advocacy, and progress. Washington, DC: AIDS Vaccine Advocacy Coalition; 1999. pp. 17– 20. Google Scholar 2Esparza J. What has 30 years of HIV vaccine research taught us? Vaccines. 2013; 1: 513– 26. doi: http://dx.doi.org/10.3390/vaccines1040513 Google Scholar 3Harmon TM, Fisher KA, McGlynn MG, Stover J, Warren MJ, Teng Y, et al. Exploring the potential health impact and cost-effectiveness of AIDS vaccine within a comprehensive HIV/AIDS response in low and middle-income countries. PLoS One. 2016; 11(1): e0146387. doi: http://dx.doi.org/10.1371/journal.pone.0146387 Google Scholar 4Rerks-Ngarm, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med. 2009; 361: 2209– 20. doi: http://dx.doi.org/10.1056/NEJMoa0908492 Google Scholar 5Haynes BF, Gilbert PB, McElrath J, Zolla-Pazner S, Tomaras GD, Alam SM, et al. Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N Engl J Med. 2012; 366: 1275– 86. doi: http://dx.doi.org/10.1056/NEJMoa1113425 Google Scholar 6Meier BM, Gelpi A, Kavanagh MW, Forman L, Amon JJ. Employing human rights frameworks to realize access to an HIV cure. JIAS. 2015; 18: 20305. doi: http://dx.doi.org/10.7448/IAS.18.1.20305 Google Scholar Volume19, Issue1January 201621252 ReferencesRelatedInformation